Log in
Novel vapour sorption experimental methods for the characterisation of complex particulate materials have been developed in the Department of Chemical Engineering. This research and expertise resulted in the creation of Surface Measurement Systems Limited (SMS), whose Dynamic Vapour Sorption (DVS) and Inverse Gas Chromatography (IGC) instruments are now found in >500 laboratories around the world. They are recognised standard research and development tools in the global pharmaceutical industry (DIN 66138). SMS has contributed >270 man-years of employment and generated £27M of turnover, whilst SMS instruments have generated over £300M of economic value, over the REF period.
Nearly all solid dosage forms contain drugs in crystalline form; and all crystals have the potential to `morph', suddenly, into different forms which can affect the safety and efficacy of the medicinal product. A number of high-profile cases in which marketed medicines had to be withdrawn [Lee, et al., Annu. Rev. Chem. Biomol. Eng. 2011, 2, 259-280] led multinational drug company Pfizer to conclude that a greater understanding of polymorphism was required to enable drug product design for the 21st Century. The University of Greenwich pioneered methods to predict crystal behaviour on the shelf and during manufacture that were affordable, timely and effective. It enabled Pfizer to select the optimal polymorphic drug form and manage risk associated with uncontrolled solid-state transformations, thereby safeguarding patients and avoiding huge costs.
One of the main functions of enclosures around electronic systems is to shield electromagnetic fields and reduce their interference with other systems. At the University of York the design of new measurement techniques for Shielding Effectiveness (SE), new instrumentation, and improved numerical model based design techniques have delivered more rigorous engineering processes for smaller equipment shielding enclosures (e.g. PCs) and large enclosures with a secondary shielding function (e.g. airframes).
These have resulted in global sales of specialist equipment to many major electronics companies through York EMC Services Ltd, a revised international standard for the measurement of SE and efficient modelling techniques to determine the SE of complex composite materials.
The cost of goods is an especially important issue in developing commercially available agrochemicals, which must be manufactured on a large scale. Richard Compton's research at the University of Oxford has led to a step change in the understanding of heterogeneous reaction mechanisms for liquid — organic solid or liquid — inorganic solid processes involved in large-scale manufacturing processes. Compton's work has had particular impact on optimising the processes used by Syngenta AG in its manufacturing of agrochemicals. Since 2008 the insights gained on inorganic-base dissolution have been of great benefit to Syngenta in its development of scalable robust manufacturing processes, particularly in relation to production of its fungicide Amistar and insecticide Actara, which are two of the world's largest selling products of this type. In 2012 Syngenta achieved total sales of over $ 14 billion, $ 4.8 billion of this from fungicide and insecticide revenues.
Methods to improve control over thermally-induced solid state transformations have been developed in Huddersfield and applied to materials synthesis and materials characterisation. Impact is being felt by catalyst and adsorbent manufacturers, where feedback-controlled thermal and microwave methods allow improved control of morphology, surface area and porosity, and possibly the nature of surface sites. New thermal characterisation methods, some based on these principles, plus calorimetric adsorption, modulated differential calorimetric and high speed thermal methods, are being applied to catalytic/adsorbent materials. The information arising from these studies is bringing economic benefit to manufacturers. The same techniques are also being applied to pyrotechnic materials, in work which has been credited with making a significant contribution to defence research in the UK and overseas.
Fingerprints remain the most conclusive means of linking an offender to a crime scene. Conventional visualization techniques require the sweat deposit to be largely retained and thus have low success rates. We have developed technologies to visualize fingerprints on metals after the sweat deposit has been substantively lost, deliberately removed or environmentally degraded. One technology uses microscale corrosion caused by the sweat deposit; it has been used in solving gun crimes. A second technology uses trace residual sweat deposit as a template to direct electrochromic polymer deposition to bare metal between the ridge deposits. These have been adopted in the new Home Office Fingerprinting Manual and licensed to UK forensic providers.
Research by the School of Pharmacy played a key role in the 2008 regulatory approval of Janssen Pharmaceutica's HIV drug Intelence®. As a poorly soluble drug, Intelence® required specialist formulation and was the first formulation of its type to be approved by the FDA and EMA. Intelence® offers significantly improved clinical outcomes due to its efficacy in patients with HIV resistance. Global Intelence® sales in 2012 were $349M, with additional not-for-profit supplies to resource-limited countries. As a result of this landmark regulatory approval formulation development strategies at Janssen were adapted enabling a further poorly soluble drug to reach the market. Telaprevir, a second-generation Hepatitis C treatment (marketed as Incivek®, Incivo® & Telavic®), gained global regulatory approval in 2011. 2012 sales exceeded $1bn in the US alone.
Nanoforce Technology Ltd. is a spin-out company wholly owned by QMUL, active in the field of polymeric and ceramic materials. Bridging the gap between academic research and industrial applications, Nanoforce has done business with over 100 companies since 2008, providing the key research expertise and specialist facilities to enable the development of new materials and commercial products, including Sugru® a room temperature vulcanizing silicone rubber, Zelfo® a self-binding cellulose material, and BiotexTM a range of high-performance yarns, fabrics and pre- consolidated sheets based renewable resources such as PLA and natural flax fibres. Nanoforce has been promoting the development and commercialisation of spark plasma sintering (SPS) since 2006, which resulted in Kennametal recently opening the first commercial SPS facility in the UK to produce advanced ceramic armour. Nanoforce's clients have included large multi-nationals such as DSM, Dow Chemical, General Electric, SABIC, L'Oreal, Shell, Sibelco, governmental agencies such as Defence Science and Technology Laboratory (Dstl), and a large number of SME's.
Nanomaterials research at Ulster into materials including diamond-like carbon (DLC) ultra-thin films, carbon nanotubes (CNT), graphene, silicon and metal oxide nanoparticles has resulted in direct uptake by major industrial manufacturers and led to a directly quantifiable socio-economic impact via added value, improved efficiencies and cost-savings and has secured or increased the employment of skilled engineering staff. Examples of this impact since 2008 include ceramic nanoparticles research in partnership with AVX Ltd that resulted in improved production efficiency processes (up 20%) and higher quality devices (up 10%). [text removed for publication] Research into ultra-thin DLC films, funded by Seagate, has led to their incorporation into magnetic media. [text removed for publication] Our nanoparticle research has attracted a new spin-in company SiSaf Ltd. (2009) and by incorporating NIBEC's expertise in nanomaterials into its business plan, the company was able to grow to a valuation of £3.5m and employ 7 people in skilled technical positions.
Super-repellent surfaces created by plasmachemical techniques invented at Durham University have been exploited by P2i as the Ion-mask™ and Adiron™ brands and used to protect the surfaces of millions of products worldwide including: 3 million pairs of footwear (Timberland, Hi- Tec); 8 million mobile phones (Nokia, Motorola, Alcatel); 60% of the world's hearing aids (HLT, GN Resound); 55,000 feet of filter media (Porvair); and 100 million pipette tips (Eppendorf). This has earned P2i industry awards including the 2011 and 2012 International Business Award for "Most Innovative Company in Europe" and the "Global Business Excellence Award" 2012. The combined turnover of P2i since 2008 was ca. £20M, it received external investment of £31.75M and has created 115 new jobs. A DU IP-holding spin-out company, Surface Innovations, was purchased by P2i in 2010, and further applications of DU plasmachemical functionalization were commercialized by Dow Corning Plasma Solutions Ltd and exploited in-period.